Success Metrics

Clinical Success Rate
89.7%

Based on 130 completed trials

Completion Rate
90%(130/145)
Active Trials
10(6%)
Results Posted
38%(50 trials)
Terminated
15(9%)

Phase Distribution

Ph phase_1
34
20%
Ph phase_2
59
34%
Ph early_phase_1
1
1%
Ph phase_4
30
17%
Ph phase_3
30
17%
Ph not_applicable
8
5%

Phase Distribution

35

Early Stage

59

Mid Stage

60

Late Stage

Phase Distribution162 total trials
Early Phase 1First-in-human
1(0.6%)
Phase 1Safety & dosage
34(21.0%)
Phase 2Efficacy & side effects
59(36.4%)
Phase 3Large-scale testing
30(18.5%)
Phase 4Post-market surveillance
30(18.5%)
N/ANon-phased studies
8(4.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.8%

130 of 148 finished

Non-Completion Rate

12.2%

18 ended early

Currently Active

10

trials recruiting

Total Trials

172

all time

Status Distribution
Active(12)
Completed(130)
Terminated(18)
Other(12)

Detailed Status

Completed130
Terminated15
unknown11
Recruiting8
Withdrawn3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
172
Active
10
Success Rate
89.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.6%)
Phase 134 (21.0%)
Phase 259 (36.4%)
Phase 330 (18.5%)
Phase 430 (18.5%)
N/A8 (4.9%)

Trials by Status

completed13076%
recruiting85%
terminated159%
not_yet_recruiting21%
active_not_recruiting21%
withdrawn32%
suspended11%
unknown116%

Recent Activity

Clinical Trials (172)

Showing 20 of 172 trialsScroll for more
NCT07420283Phase 2

A Study of Brenipatide in Participants With Opioid Use Disorder

Recruiting
NCT07435077Phase 4

Examining Analgesic Synergy and Efficacy in Trauma Care

Not Yet Recruiting
NCT04276259Phase 4

Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses

Completed
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07176351Phase 4

Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic

Not Yet Recruiting
NCT06008990

Maternal Brain Imaging in Opioid Use Disorder

Active Not Recruiting
NCT03150173Phase 2

Onsite Buprenorphine Treatment at Syringe Exchange Programs

Completed
NCT06316830Phase 2

Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose

Recruiting
NCT06086275Phase 1

Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder

Completed
NCT06379984Phase 2

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use

Recruiting
NCT03646058Phase 3

Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode

Recruiting
NCT06494904Phase 3

Standard Versus High Dose ED-Initiated Buprenorphine Induction

Recruiting
NCT04752384Phase 2

Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients

Completed
NCT06406400Phase 1

Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

Terminated
NCT04116528Phase 3

Opiate Suicide Study in Patients With Major Depression

Active Not Recruiting
NCT04571619Phase 2

HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis

Completed
NCT04981678Phase 4

The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder

Terminated
NCT03605342Phase 2

Optimal Treatment of Veterans With PTSD and Comorbid OUD

Terminated
NCT06133114Phase 4

Psychopharmacological Treatment of Emotional Distress

Recruiting
NCT05164549Phase 3

Extended-release Pharmacotherapy for Opioid Use Disorder

Completed

Drug Details

Intervention Type
DRUG
Total Trials
172